Poland
· Delayed Price · Currency is PLN MedApp Statistics
Total Valuation
MedApp has a market cap or net worth of PLN 43.02 million. The enterprise value is 48.96 million.
| Market Cap | 43.02M |
| Enterprise Value | 48.96M |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedApp has 250.13 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 250.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 120.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.80 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.29, with an EV/FCF ratio of -58.99.
| EV / Earnings | -253.67 |
| EV / Sales | 6.60 |
| EV / EBITDA | 10.29 |
| EV / EBIT | n/a |
| EV / FCF | -58.99 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.67 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | -3.97 |
| Interest Coverage | 0.30 |
Financial Efficiency
Return on equity (ROE) is -0.46% and return on invested capital (ROIC) is 0.09%.
| Return on Equity (ROE) | -0.46% |
| Return on Assets (ROA) | 0.08% |
| Return on Invested Capital (ROIC) | 0.09% |
| Return on Capital Employed (ROCE) | 0.16% |
| Revenue Per Employee | 463,813 |
| Profits Per Employee | -12,063 |
| Employee Count | 16 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 0.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.45% in the last 52 weeks. The beta is 1.11, so MedApp's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -50.45% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.20 |
| Relative Strength Index (RSI) | 56.36 |
| Average Volume (20 Days) | 38,859 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedApp had revenue of PLN 7.42 million and -193,000 in losses. Loss per share was -0.00.
| Revenue | 7.42M |
| Gross Profit | 2.59M |
| Operating Income | 44,000 |
| Pretax Income | -98,000 |
| Net Income | -193,000 |
| EBITDA | 4.76M |
| EBIT | 44,000 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 123,000 in cash and 3.30 million in debt, giving a net cash position of -3.17 million or -0.01 per share.
| Cash & Cash Equivalents | 123,000 |
| Total Debt | 3.30M |
| Net Cash | -3.17M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 26.61M |
| Book Value Per Share | 0.10 |
| Working Capital | 16.51M |
Cash Flow
In the last 12 months, operating cash flow was -789,000 and capital expenditures -41,000, giving a free cash flow of -830,000.
| Operating Cash Flow | -789,000 |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -830,000 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 34.83%, with operating and profit margins of 0.59% and -2.60%.
| Gross Margin | 34.83% |
| Operating Margin | 0.59% |
| Pretax Margin | -1.32% |
| Profit Margin | -2.60% |
| EBITDA Margin | 64.10% |
| EBIT Margin | 0.59% |
| FCF Margin | n/a |
Dividends & Yields
MedApp does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.45% |
| FCF Yield | -1.93% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedApp has an Altman Z-Score of 4.37.
| Altman Z-Score | 4.37 |
| Piotroski F-Score | n/a |